Prosecution Insights
Last updated: August 15, 2026

Uti Limited Partnership

10 pending office actions • 6 art units • 9 examiners • 0 of 10 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days

Portfolio Summary

10
Total Pending OAs
6
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

7
Hard (70%)
3
Medium (30%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (10%)
§103 only3 (30%)
Multi-statute (no §101)6 (60%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
60% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
10% of docket
3
Business / Other
30% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DIBRINO, MARIANNE 2 43.2% +41.6%
MOORE, WHITNEY 1 88.1% +10.0%
VU, QUYNH-NHU HOANG 1 68.3% +27.5%
HAILEY, PATRICIA L 1 88.1% +10.1%
WITHERSPOON, SIKARL A 1 86.2% -20.3%
HOU, FRANK S 1 70.8% +33.5%
TSUI, YUNG-SHENG M 1 66.5% +7.2%
JOHNSON, CHRISTOPHER LINDSAY 1 51.7% +77.8%
SABILA, MERCY HELLEN 1 57.6% +45.9%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18290692 METAL ORGANIC FRAMEWORK FILM AND METHOD OF MAKING WITHERSPOON, SIKARL A

Hard Cases (7)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18026397 METHODS OF TREATING AND/OR PREVENTING ALZHEIMER’S DISEASE WITH R-CARVEDILOL JOHNSON, CHRISTOPHER LINDSAY 66d overdue
18273312 CHROMIUM PHOSPHONATE METAL-ORGANIC FRAMEWORKS, PROCESS FOR PREPARING THE SAME AND USES THEREOF HOU, FRANK S 21d
18744298 SYSTEM AND METHOD FOR GLOBAL REAL-TIME KINEMATIC PRECISE POSITIONING MOORE, WHITNEY
18691764 SORBENTS AND METHODS FOR CARBON CAPTURE VIA CALCIUM LOOPING HAILEY, PATRICIA L
18256434 SYSTEM AND METHOD FOR PROCESSING FIBER-REINFORCED COMPOSITES IN ADDITIVE MANUFACTURING TSUI, YUNG-SHENG M
18048339 METHODS FOR TREATING AUTOIMMUNE DISEASE USING BIOCOMPATIBLE BIOABSORBABLE NANOSPHERES DIBRINO, MARIANNE
17661873 METHODS AND COMPOSITIONS FOR SUSTAINED IMMUNOTHERAPY DIBRINO, MARIANNE

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18026397 METHODS OF TREATING AND/OR PREVENTING ALZHEIMER’S DISEASE WITH R-CARVEDILOL JOHNSON, CHRISTOPHER LINDSAY 66d overdue
17532578 NANOPARTICLES COMPRISING NON-CLASSICAL MHC AND USES THEREOF SABILA, MERCY HELLEN 19d overdue
18273312 CHROMIUM PHOSPHONATE METAL-ORGANIC FRAMEWORKS, PROCESS FOR PREPARING THE SAME AND USES THEREOF HOU, FRANK S 21d
18744298 SYSTEM AND METHOD FOR GLOBAL REAL-TIME KINEMATIC PRECISE POSITIONING MOORE, WHITNEY
18701047 MICRONEEDLE AND ARRAY AND METHOD OF FABRICATING SAME VU, QUYNH-NHU HOANG
18691764 SORBENTS AND METHODS FOR CARBON CAPTURE VIA CALCIUM LOOPING HAILEY, PATRICIA L
18048339 METHODS FOR TREATING AUTOIMMUNE DISEASE USING BIOCOMPATIBLE BIOABSORBABLE NANOSPHERES DIBRINO, MARIANNE
17661873 METHODS AND COMPOSITIONS FOR SUSTAINED IMMUNOTHERAPY DIBRINO, MARIANNE

Top Art Units

Art UnitApps
1641 2
3646 1
1692 1
1743 1
1691 1
1654 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18744298 SYSTEM AND METHOD FOR GLOBAL REAL-TIME KINEMATIC PRECISE POSITIONING MOORE, WHITNEY 3646 §101§102§103 Non-Final OA Pending Jun 14, 2024
18701047 MICRONEEDLE AND ARRAY AND METHOD OF FABRICATING SAME VU, QUYNH-NHU HOANG §103 Non-Final OA Pending Apr 12, 2024
18691764 SORBENTS AND METHODS FOR CARBON CAPTURE VIA CALCIUM LOOPING HAILEY, PATRICIA L §102§112 Non-Final OA Pending Mar 13, 2024
18290692 METAL ORGANIC FRAMEWORK FILM AND METHOD OF MAKING WITHERSPOON, SIKARL A §103 Non-Final OA Pending Jan 19, 2024
18273312 CHROMIUM PHOSPHONATE METAL-ORGANIC FRAMEWORKS, PROCESS FOR PREPARING THE SAME AND USES THEREOF HOU, FRANK S 1692 §102§103 Non-Final OA 21d Pending Jul 20, 2023
18256434 SYSTEM AND METHOD FOR PROCESSING FIBER-REINFORCED COMPOSITES IN ADDITIVE MANUFACTURING TSUI, YUNG-SHENG M 1743 §102§103§112 Final Rejection Pending Jun 08, 2023
18026397 METHODS OF TREATING AND/OR PREVENTING ALZHEIMER’S DISEASE WITH R-CARVEDILOL JOHNSON, CHRISTOPHER LINDSAY 1691 §102§103§112 Non-Final OA 66d overdue Pending Mar 15, 2023
18048339 METHODS FOR TREATING AUTOIMMUNE DISEASE USING BIOCOMPATIBLE BIOABSORBABLE NANOSPHERES DIBRINO, MARIANNE 1641 §103§112 Final Rejection Pending Oct 20, 2022
17661873 METHODS AND COMPOSITIONS FOR SUSTAINED IMMUNOTHERAPY DIBRINO, MARIANNE 1641 §103§112 Final Rejection Pending May 03, 2022
17532578 NANOPARTICLES COMPRISING NON-CLASSICAL MHC AND USES THEREOF SABILA, MERCY HELLEN 1654 §103 Final Rejection 19d overdue Pending Nov 22, 2021

Managing Uti Limited Partnership's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month